NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-233-2014-0-JP-11 METHODS FOR ISOLATING T CELL RECEPTORS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS JP DIV 2022-077983 Issued
NIAID E-228-2016-1-US-14 STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US CON 17/742,201 11793871 Issued PDF
NCI E-096-2021-0-PCT-02 LABELING BIOLOGICAL PARTICLES USING ACOUSTOPHORESIS PCT PCT PCT/US2022/028819 Expired
NHLBI E-127-2021-2-PCT-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES PCT PCT COMB PCT/US2022/028510 Expired
NCI E-244-2015-0-EP-13 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use EP DIV 22172554.2 Pending
NCI E-126-2022-0-US-01 VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1 US 63/340,400 Expired
NEI E-192-2014-1-AU-11 Surgical Tool and Method for Ocular Tissue Transplantation AU DIV 2022203098 Issued
NICHD E-115-2022-0-US-01 NESTORONE® / TESTOSTERONE TRANSDERMAL GEL US 63/339,563 Expired
NIDA E-053-2016-2-US-07 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF US CON 17/738,301 12097196 Issued PDF
NCI E-101-2021-0-PCT-02 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 PCT PCT PCT/US2022/028066 Expired
NCI E-192-2020-2-US-02 USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS US National Stage 17/775,262 Pending
NHLBI E-061-2022-0-US-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL
RESYNCHRONIZATION AND PACING 		US 63/364,319 Expired
NHLBI E-119-2022-0-US-01 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE US 63/338,654 Expired
NIAID E-128-2016-0-EP-07 MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONOVIRUSES EP DIV 22171378.7 Pending
NEI E-293-2016-0-JP-08 TISSUE CLAMP AND IMPLANTATION METHOD JP DIV 2022-075904 Issued
NCI E-048-2022-0-US-01 COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS US 63/337,296 Expired
NHLBI E-123-2022-0-US-02 SYSTEMS AND METHODS FOR SPIRAL-IN-OUT LOW FIELD MRI SCANS US ORD 17/733,970 11747419 Issued PDF
NIAID E-089-2022-0-PCT-02 PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE PCT PCT PCT/US2022/027136 Expired
NCI E-099-2021-0-PCT-02 LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE PCT PCT PCT/US2022/027082 Expired
NCI E-079-2020-2-US-02 IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN US National Stage 17/773,494 Pending
NIDA E-122-2022-0-US-02 ANTIBODIES AGAINST FENTANYL AND FENTANYL ANALOGS US ORD 17/661,160 12472248 Issued PDF
NHLBI E-142-2021-0-US-02 METHODS AND SYSTEMS FOR MAXWELL COMPENSATION FOR SPIN-ECHO TRAIN IMAGING US ORD 17/732,155 11860258 Issued PDF
NIDDK E-126-2021-0-PCT-02 Purine Nucleosides, Their Intermediates, And Methods Of Preparation Thereof PCT PCT PCT/US2022/071971 Expired
NINDS E-113-2022-0-US-01 RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2 US 63/335,824 Expired
NIAID E-239-2020-0-PCT-02 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE PCT PCT PCT/US2022/026576 Expired
NEI E-227-2018-0-CN-06 Druggable Taraget to Treat Retinal Degeneration CN National Stage 202080075532.5 Pending
NIBIB E-118-2022-0-US-01 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION
AND CANCER 		US 63/335,527 Expired
NCI E-127-2022-0-US-01 COMPOSITIONS AND METHODS FOR ASSEMBLING DECELLULARIZED TISSUE EXTRACELLULAR MATRIX IN THREE DIMENSIONAL SPHEROIDS US 63/335,555 Expired
NIAID E-221-2022-2-PC-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE PCT PCT PCT/US2022/026409 Expired
NIAID E-221-2022-2-CN-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE CN National Stage 202280037491.X Pending
NHGRI E-175-2019-0-EP-03 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA EP National Stage 20804709.2 Pending
NIDCR E-196-2021-0-US-01 Lens Array Based Imaging System with Improved Field of View US 63/334,399 Expired
NIA E-062-2021-0-PCT-02 HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE PCT PCT PCT/US2022/025764 Expired
NCI E-185-2019-0-US-08 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors US National Stage 17/770,940 Pending
NIAID E-202-2018-0-US-03 PST2238 (Rostafuroxin) As An Antiviral Drug Against Respiratory Syncytial Virus (RSV) US DIV 17/725,331 Abandoned
NCI E-065-2015-0-US-14 GRIFFITHSIN MUTANTS US CON 17/724,342 12384820 Issued PDF
NIAID E-139-2006-0-US-71 DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS US CON 17/724,037 11746335 Issued PDF
NCI E-191-2019-0-PCT-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION PCT PCT PCT/US2022/025177 Expired
NIBIB E-005-2012-3-CN-13 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS CN DIV 202210413867.4 Issued
NIAID E-216-2014-0-US-17 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES US CON 17/721,188 Abandoned
NIAID E-090-2021-0-US-01 Bispecific Antibodies To Ebola Virus Glycoprotein And Their Use US 63/330,877 Expired
NEI E-227-2018-0-ID-08 Druggable Taraget to Treat Retinal Degeneration ID National Stage P-00202204386 Pending
NIA E-151-2017-0-US-12 FATTY ACID DERIVATIVES AND THEIR USE US DIV 17/718,965 12479812 Issued PDF
NCI E-190-2014-0-AU-46 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS AU DIV 2022202408 Issued
NCI E-174-2018-2-GB-18 TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY GB DIV 2205417.5 Issued
NIAID E-089-2022-0-US-01 PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE US 63/329,886 Expired
NEI E-227-2018-0-KR-11 Druggable Taraget to Treat Retinal Degeneration KR National Stage 10-2022-7012050 Pending
NCI E-030-2022-0-EP-01 Anti-Viral Compositions And Methods Of Making And Using EP National Stage 20862862.8 Pending
NCI E-139-2015-0-US-05 FIXATIVES AND METHODS OF USE US DIV 17/716,606 12270738 Issued PDF
NEI E-227-2018-0-IN-09 DRUGGABLE TARGET TO TREAT RETINAL DEGENERATION IN National Stage 202247021119 Pending